Our Members

Aishwarya Ravindran, M.D.

Dr. Aishwarya Ravindran is a consultant Hematopathologist at the University of Alabama at Birmingham (UAB) and an Associate Scientist in Cancer Control and Population Science at the O’Neal Comprehensive Cancer Center at UAB. She received her medical degree from Stanley medical college in India. Subsequently, she pursued her research fellowship in Hematology, followed by a residency in Anatomic/Clinical Pathology and a fellowship in Hematopathology at Mayo Clinic in Rochester, Minnesota. During her research years, she developed a special interest in studying rare diseases, specifically histiocytic/dendritic cell neoplasms. Besides a busy clinical practice, her academic research focuses on analyzing the phenotypic and genotypic correlates in histiocytic/dendritic cell neoplasms and integration into clinical diagnostics. She has published numerous peer-reviewed scientific articles and was also a recipient of the Mayo Clinic Dr. Hobart K.B. Allebach Fellowship award and the American Society of Clinical Pathology- 40 under forty honoree for outstanding contributions to the field of pathology. As an active member of the multidisciplinary Histio-Care Network, she aims to improve awareness about these rare diseases.

Karen L. Rech, M.D.

Dr. Rech is a Professor of Hematopathology and Medical Co-director of the Immunostains Laboratory at the Mayo Clinic in Rochester, MN, USA. She received her MD from the University of North Carolina-Chapel Hill, followed by residency and fellowship training at Mayo Clinic Graduate School of Medicine. Inspired by a busy clinical practice, her research interests focus on novel diagnostic markers in hematopathology. As a founding member of the multidisciplinary Mayo Clinic Histiocytosis Working Group, she has developed unique expertise in the pathologic diagnosis of histiocytic neoplasms. Her expertise is shared through her pathology consultation practice, educational seminars to pathologists worldwide, and seminal publications on the pathological features of Rosai-Dorfman disease, Erdheim-Chester disease and malignant histiocytic neoplasms. She currently serves on the Non-LCH Steering Committee for the Histiocyte Society.

Diana Morlote, M.D.

Diana Morlote earned her medical degree from the Herbert Wertheim College of Medicine before completing anatomic and clinical pathology residency at Mount Sinai Medical Center in Miami, Florida, in 2017. She joined the University of Alabama at Birmingham (UAB) Department of Pathology as a molecular genetic pathology fellow. Upon completion of one fellowship, Dr. Morlote began her second in hematopathology at UAB. In 2019, she joined the department as an assistant professor.

Dr. Morlote is board certified in Molecular Genetic Pathology and Hematopathology. Her research interests focus on the molecular characterization of hematologic neoplasms and their diagnostic and prognostic implications. She serves as Director of the Hematopathology Fellowship and leads the Hematopathology resident rotation. She is Chair of the Critical Values Committee and one of the module directors for the Hematology-Oncology Module at the Heersink School of Medicine at UAB. In addition, she serves as director of two UAB Outreach Service Labs in the McDonald Clinic and Urgent Care.

Liuyan (Jennifer) Jiang, M.D.

Dr. Liuyan (Jennifer) Jiang was born and raised in Shanghai, China. After she graduated from Shanghai First Medical University (current Fudan University Shanghai Medical College), Dr. Jiang pursued anatomic and clinical pathology residence training at University of Texas at Houston Medical school. Subsequently she completed surgical pathology fellowship at University of Texas MD Anderson Cancer Center, Houston, TX; then hematopathology fellowship at National Institutes of Health/ National Cancer Institute, Bethesda, MD.

Dr. Jiang joined Mayo Clinic Florida immediately after completion of fellowship in 2008. She served as a general pathologist at the beginning of the career; later she focused on the Hematopathology service. She had been the medical director of flow cytometry laboratory for approximately fifteen years; then promoted to the division director of Hematopathology at Mayo Clinic Florida since 2022. Dr. Jiang currently is a Professor of Laboratory Medicine and Pathology at Mayo Clinic School of Medicine and Science.

Dr. Jiang’s clinical practice and research encompasses three broad areas: developing biomarkers in B cell lymphomas and T cell lymphomas for pathogenesis and treatment options; conducting immunohistochemistry and/or flow cytometry analysis for certain antigens on neoplastic lymphocytes for treatment choice; and epidemiologic and biostatistical study on relationship in clinical phenotype, molecular genetic mutation, and treatment outcome in acute leukemia. Her recent research focuses on tumor micro-environment associated with lymphomas and plasma cell disorders, molecular genetic progression in myeloid neoplasm pre- and post-bone marrow transplant. With the expansion of clinical practice and research at MCF, Dr. Jiang recently developed keen interest in the diagnosis, pathogenesis, and new treatment in histiocytic disorders. She participated in the Histiocytic working group since 2023 and now is the active member of Histio-Care Netwrok.